Notice of Effectiveness
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: May 4, 2023
Accession Number: 0001628280-23-014558
Submission Type: POS AM
CIK: 0001821586
Company Name: MoonLake Immunotherapeutics
File Number: 333-262643